Radiography
Volume 13 , Pages e90-e98 , December 2007

A pilot study to investigate the effect of a hydration regime upon immediate and 24h delayed MRI contrast agent reactions

  • William Bailey

      Affiliations

    • Medical Imaging, Leighton Hospital, Mid Cheshire Hospital Trust, Middlewich Road, Crewe, Cheshire CW1 4QJ, UK
    • Present address: Cross Section Imaging, Manchester Royal Infirmary, Oxford Road, Manchester, UK.
    • Corresponding Author InformationCorresponding author. Tel.: +44 1270 612505.
    • ,
  • Gill Marshall

      Affiliations

    • Chair of Faculty Academic Standards International Projects Leader, Faculty of Health and Social Care, St. Martin's College, Lancaster LA1 3JD, UK
    • ,
  • Jacqui Coals

      Affiliations

    • Medical Imaging, Leighton Hospital, Mid Cheshire Hospital Trust, Middlewich Road, Crewe, Cheshire CW1 4QJ, UK
    • Present address: Cross Section Imaging, Manchester Royal Infirmary, Oxford Road, Manchester, UK.

Received 4 December 2006 ,Accepted 6 February 2007.

References 

  1. National Imaging Associates, <http://www.radmd.com/index.html>; updated 21.6.2006.
  2. Schering Healthcare Limited. Sales and marketing statement. Burgess Hill; 2006.
  3. Miles AK, Runge VM. Contrast agents for MRI safety update. Top Magnetic Resonance Imaging. 2003;14(5):426–435
  4. Tweedle MF, Eaton S, Eckelman W, Gaughan GT, Hagan JJ, Wedeking PW, et al. Comparative chemical structure and pharmacokinetics of MRI contrast agents. Investigative Radiology. 1988;23(1):236–239
  5. Runge VM. Safety of approved MR contrast media for intravenous injection. Journal of Magnetic Resonance Imaging. 2000;12:205–221
  6. Kirchin MA, Runge VM. Contrast agents for magnetic resonance imaging safety update. Top Magnetic Resonance Imaging. 2003;14(5):426–435
  7. Laniado M, Weinmann HJ, Schorner W. First use of Gd-DTPA/dimeglumine in man. Physiological Chemistry & Physics & Medical NMR. 1984;16:157–165
  8. Hilty C, Wider G, Fernandez C, Wuthrich K. Membrane protein–lipid interactions in mixed mucelles studied by NMR spectroscopy with the use of paramagnetic reagents. Chemical Biochemistry. 2004;5:467–473
  9. Runge VM. The safety of MR contrast media: a literature review. Applied Radiology (Supplement). 2001;12:8–14
  10. Shellock FG, Kanal E. Bioeffects and safety. In:  Stark DD,  Bradley WG editor. Magnetic resonance imaging. St. Louis: Mosby; 1999;p. 291–306
  11. Jordan RM, Mintz RD. Fatal reaction to gadopentetate dimeglumine. American Journal of Roentgeology. 1995;164:743–744
  12. Nelson KL, Gilford LM, Lauber-Huber C, Gross CA, Lasser TA. Clinical safety of gadopentetate dimeglumine. Radiology. 1995;196:439–443
  13. Kanal E, Applegate G, Gillen C. Review of adverse reactions, including anaphylaxis, in 5260 cases receiving Gd-DTPA by bolus injection. Radiology. 1990;177:159
  14. Brugieres P, Gaston A, Degryse HR, Parizel PM, Schepper AM, Berry I, et al. Randomised double-blind trial of the safety and efficiency of two gadolinium complexes (Gd-DTPA/DOTA). Neuroradiology. 1994;36:27–30
  15. Olukotun AY, Parker JR, Meeks MJ, Lucas MA, Fowler DR, Lucas TR. Safety of gadoteridol injection: the US clinical trial experience. Journal of Magnetic Resonance Imaging. 1995;5:17–25
  16. Sze G, Brank T, Zawadzki MN, Haughton VM, Maravilla KR, McNamara MT, et al. Multi-centre study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine. Radiology. 1991;76:513–518
  17. Ekholm S, Jonsson E, Sandvik L, Fagerlund M, Holtas S, Isberg B, et al. Tolerance and efficiency of omniscan in MR imaging of the central nervous system. Acta Radiology. 1996;37:223–228
  18. Kirchin MA, Pirovano G, Venetianer K, Spinazzi A. Safety assessment of gadovenate dimeglumine (MultiHance): extended clinical experience from phase 1 studies to post marketing surveillance. Journal of Magnetic Imaging. 2001;14:281–294
  19. Brown JJ, Kristy RM, Stephens GR, Peirro JA. The OptiMARK clinical development program; summary of safety data. British Journal of Magnetic Imaging. 2002;15:445–446
  20. Department of Health. Patient group directions: summary of product characteristics, <http://www.dh.gov.uk/PolicyAndGuidance/EmergencyPlanning/EmergencyPreparednessArticle/fs/en?CONTENTID=4069610&chk=in7ZEF>; last updated Jan 2006.
  21. College of Radiographers . Prescribing by radiographers: a vision paper. London: College of Radiographers; 2001;
  22. Department of Health . Final report on prescribing, supply and administration of medicines. London: Department of Health; 1999;
  23. Department of Health . Radiography programme launches new beacon sites. Allied Health Professionals Bulletin. 2005;39:
  24. Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology Guidelines. British Journal of Radiology. 2003;76:513–518
  25. Thomsen HS. How to avoid contrast induced nephrotoxicity. Lisbon: European Society of Urogenital Radiology; 2004;
  26. Bowling A. Research methods in health: investigating health and health sciences. 1st ed.. Buckingham: Open University Press; 1997;p. 135
  27. Marshall MG. Questionnaire design: asking questions for a purpose. 201 Hiram Smith Hall, 1545 Observatory Drive, Madison, USA: University of Wisconsin; 1996. <http://cecommerce.uwex.edu/pdfs/G36582.PDF>.
  28. Niendorf HP, Dinger JC, Haustein J, Cornelius I, Alhassan A, Clauss W. Tolerance data of Gd-DTPA: a review. European Journal of Radiology. 1991;13:15–20
  29. Murphy KJ, Brunberg JA, Cohan RH. Adverse reactions to gadolinium contrast media: a review of 36 cases. American Journal of Radiology. 1996;167:847–849
  30. Sahni H, Jayakumar PN, Lalla RK, Vasudev MK, Kovoor JME. Anaphylactoid reaction following intravenous gadolinium dimeglumine – a case report. India Journal of Radiological Imaging. 2002;12(1):81–82
  31. Shellock FG, Kanal E. Safety of magnetic imaging contrast agents. Journal of Magnetic Resonance Imaging. 1999;10:477–484
  32. Goldstein HA, Kashanian FK, Blumetti R, Holyoak WL, Hugo FP, Blumenfield DM. Safety assessment of Gd-DTPA in U.S. clinical trials. Radiology. 1990;174:17–23

PII: S1078-8174(07)00013-2

doi: 10.1016/j.radi.2007.02.005

Radiography
Volume 13 , Pages e90-e98 , December 2007

Article Tools

* Image Usage & Resolution